
    
      This study will be a prospective, multi-center, randomized, double-arm, single blind,
      concurrently controlled study to assess the safety and efficacy of the ProSpace Balloon in
      prostate cancer subjects undergoing radiotherapy by means of intensity modulation radiation
      therapy (IMRT).
    
  